← Open Payments lookup

GLENDA GROVENBERRY: Open Payments

NPI 1295343689 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$979 in 53 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $225 · 2025 $979

Food & beverage: $979
CompanyPaymentsAmount
Alkermes, Inc.9$194
Otsuka America Pharmaceutical, Inc.10$170
E.R. Squibb & Sons, L.L.C.10$143
Teva Pharmaceuticals USA, Inc.6$130
Neurocrine BioSciences, Inc.4$91
ABBVIE INC.4$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$58
Janssen Pharmaceuticals, Inc2$38
Azurity Pharmaceuticals, Inc.1$26
Tris Pharma Inc1$21

Products named: ARISTADA, COBENFY, AUSTEDO XR, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, REXULTI, VRAYLAR.

Industry payments across IN — which companies pay providers there.